Adana City Research and Education Hospital, Adana, Turkey.
Sleep Breath. 2024 Jun;28(3):1245-1250. doi: 10.1007/s11325-024-02999-1. Epub 2024 Feb 3.
To investigate the prevalence of treatment-emergent central sleep apnea (TECSA) in individuals with obstructive sleep apnea syndrome (OSAS) during continuous positive airway pressure (CPAP) titration and assess their polysomnographic characteristics.
A total of 116 patients with OSAS who underwent full-night CPAP titration at the Sleep Laboratory of Adana City Research and Education Hospital from September 2017 to January 2018 were recruited for the study. The patients' polysomnographic data related to respiratory events and sleep stages were reviewed in a retrospective manner.
While on CPAP titration, 20 of the 116 patients developed central sleep apnea (CSA). The prevalence of TECSA in the patients with OSAS was 17.2%, being separately determined as 16.3% and 2.2% for the male and female patients, respectively. In the baseline PSG, the groups did not statistically significantly differ in relation to the apnea hypopnea index (AHI), central apnea index (CAI), arousal index (AI), or oxygen desaturation index (ODI). However, the TECSA group had a significantly higher mean oxygen saturation value compared to the non-TECSA group (p = 0.01). The total AHI, CAI, and AI values of the TECSA group were significantly higher during the whole CPAP titration compared to the non-TECSA group. No significant difference was observed in the comparison of the two groups in relation to the titration pressure and ODI.
TECSA is a phenomenon that can occur with obstructive sleep apnea treatment and mostly regress spontaneously following appropriate CPAP treatment. TECSA is observed at different rates of prevalence. In this study, the prevalence of TECSA was higher than previously reported.
研究阻塞性睡眠呼吸暂停综合征(OSAS)患者在持续气道正压通气(CPAP)滴定过程中治疗性中枢性睡眠呼吸暂停(TECSA)的发生率,并评估其多导睡眠图特征。
回顾性分析 2017 年 9 月至 2018 年 1 月在阿达纳城市研究和教育医院睡眠实验室接受整夜 CPAP 滴定的 116 例 OSAS 患者的多导睡眠图数据。
在 CPAP 滴定过程中,116 例患者中有 20 例发生中枢性睡眠呼吸暂停(CSA)。OSAS 患者 TECSA 的患病率为 17.2%,男性和女性患者分别为 16.3%和 2.2%。在基线 PSG 中,两组在呼吸暂停低通气指数(AHI)、中枢性呼吸暂停指数(CAI)、觉醒指数(AI)或氧减饱和度指数(ODI)方面无统计学差异。然而,TECSA 组的平均氧饱和度值明显高于非 TECSA 组(p=0.01)。与非 TECSA 组相比,TECSA 组在整个 CPAP 滴定过程中的总 AHI、CAI 和 AI 值均显著升高。两组在滴定压力和 ODI 方面无显著差异。
TECSA 是阻塞性睡眠呼吸暂停治疗中可能出现的一种现象,在接受适当 CPAP 治疗后大多会自发消退。TECSA 的发生率存在差异。在本研究中,TECSA 的患病率高于以往报道。